The PE Ratio as of July 2024 (TTM) for Moderna, Inc. (MRNA) is -7.68

According to Moderna, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -7.68. This represents a change of -228.14% compared to the average of 5.99 of the last 4 quarters.

Moderna, Inc. (MRNA) Historical PE Ratio (quarterly & annually)

How has MRNA PE Ratio performed in the past?

The mean historical PE Ratio of Moderna, Inc. over the last ten years is -15.00. The current -7.68 PE Ratio has changed 5.02% with respect to the historical average. Over the past ten years (40 quarters), MRNA's PE Ratio was at its highest in in the March 2023 quarter at 187.60. The PE Ratio was at its lowest in in the June 2020 quarter at -51.91.

Moderna, Inc. (MRNA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Moderna, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Moderna, Inc. (MRNA) Average PE Ratio

How has MRNA PE Ratio performed in the past?

The current PE Ratio of Moderna, Inc. (MRNA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Moderna, Inc. (MRNA) PE Ratio vs. Peers

How is MRNA’s PE Ratio compared to its peers?

Moderna, Inc.’s PE Ratio is less than CureVac N.V. (-2.83), less than Novavax, Inc. (-6.00), less than CohBar, Inc. (-0.12), greater than Reata Pharmaceuticals, Inc. (-89.36), less than Ocean Biomedical, Inc. (0), less than Enveric Biosciences, Inc. (-0.22), less than Hepion Pharmaceuticals, Inc. (-0.12), less than Elevation Oncology, Inc. (-0.10), less than AVROBIO, Inc. (-3.53), less than Rain Therapeutics Inc. (2.07), less than Krystal Biotech, Inc. (-0.62), less than Intellia Therapeutics, Inc. (105.76), less than Editas Medicine, Inc. (-5.21), less than Vertex Pharmaceuticals Incorporated (-2.79), less than Beam Therapeutics Inc. (31.81), greater than Ginkgo Bioworks Holdings, Inc. (-20.09), less than null (-0.87),

Build a custom stock screener for Moderna, Inc. (MRNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Moderna, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Moderna, Inc. (MRNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Moderna, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.